Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesNexavar in Combination with Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free Survival
BayNews International, 09/24/09
Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. announced the full results from their first collaborative group–sponsored randomized, double–blind, placebo controlled Phase II trial showing that Nexavar in combination with the oral chemotherapeutic agent, capecitabine, significantly extended progression–free survival in patients with advanced breast cancer by 74 percent.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children – a double-blind randomized study
Alimentary Pharmacology and Therapeutics, 12/04/09
The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials
BMC Infectious Diseases, 12/03/09
Sponsor
Article Search
Sponsor